✦ LIBER ✦

Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial

✍ Scribed by Al-Khatib, S. M.; Thomas, L.; Wallentin, L.; Lopes, R. D.; Gersh, B.; Garcia, D.; Ezekowitz, J.; Alings, M.; Yang, H.; Alexander, J. H.; Flaker, G.; Hanna, M.; Granger, C. B.

Book ID: 125505784
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 323 KB
Volume: 34
Category: Article
ISSN: 0195-668X
DOI: 10.1093/eurheartj/eht135

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes With Apixaban by Type of Atrial

Outcomes With Apixaban by Type of Atrial Fibrillation: Results From the Aristotle Trial

✍ Al-Khatib, Sana; Thomas, Laine; Wallentin, Lars; Lopes, Renato; Gersh, Bernard; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Efficacy and Safety of Apixaban Compared

Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

✍ Goto, Shinya; Zhu, Jun; Liu, Lisheng; Oh, Byung-Hee; Wojdyla, Daniel M.; Aylward 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Apixaban compared with warfarin in patie

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial

✍ J Donald Easton; Renato D Lopes; M Cecilia Bahit; Daniel M Wojdyla; Christopher 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 264 KB

900 Efficacy and safety of apixaban comp

900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial

✍ J. Ezekowitz; P. Dorian; C. Granger; J. Alexander; R. Lopes; M. Hanna; M. Gerald 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 72 KB

Medical cost reductions associated with

Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials

✍ Deitelzweig, Steve; Amin, Alpesh; Jing, Yonghua; Makenbaeva, Dinara; Wiederkehr, 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 511 KB

Use and outcomes of antiarrhythmic thera

Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: Results from the ROCKET AF trial

✍ Steinberg, Benjamin A.; Hellkamp, Anne S.; Lokhnygina, Yuliya; Halperin, Jonatha 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 615 KB